The EU Medical Device Regulatory Affairs Conference will virtually connect industry leaders to dive deeper into the activities focused on achieving the transition towards the MDR and reorganize priorities, especially with the Medical Device Regulation date of application now postponed by a year. The program will be delivered in three online modules:

Module 1: Multi-Perspective Dive into the Impact Of MDR DOA Postponement on the Industry
Module 2: Pragmatic Focus on Overcoming Ongoing Areas of Challenge with MDR Implementation
Module 3: First MDR Certification Experiences: Practical Overview & Lessons Learned

Strategizing to best prioritize operations necessary to finalize the transition towards the new rules is at the forefront of the industry’s concern, and is challenged by a number of unknown factors that will ultimately influence strategies. As manufacturers aim to finalize compliance for the most pressing product lines first, such as most Class I, or devices with MDD certificates ending close to the spring of 2020, many professionals are eager to obtain insight from similar industry experiences in order to compare and debate time and cost-effective strategies.

While long-awaited MDCG guidance has been issued in recent months, the industry is still eager to see further light shed on ongoing areas of uncertainty in both pre and post-market regulatory requirements, in order to optimize the use of the new timeline for compliance. Learning from peers’ experience in obtaining MDR certificates is at the forefront of regulatory professionals’ interest, in order to gain practical insight in interactions with notified bodies as well as fixing non-conformities to ultimately reach the new CE mark goals.